Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia

Atherosclerosis - Tập 119 - Trang 89-98 - 1996
Jürgen Dobmeyer1, Jens Lohrmann1, Giso Feussner1
1Department of Internal Medicine I, Endocrinology and Metabolism, University of Heidelberg, Bergheimer Strasse 58, D-69115 Heidelberg, Germany

Tài liệu tham khảo

Mahley, 1989, Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism, 1195 Brewer, 1983, Type III hyperlipoproteinemia: Diagnosis, molecular defects pathology, and treatment, Ann Intern Med, 98, 623, 10.7326/0003-4819-98-5-623 Havel, 1982, Familial dysbetalipoproteinemia: New aspects of pathogenesis and diagnosis, Med Clin North Am, 66, 441, 10.1016/S0025-7125(16)31429-8 Morganroth, 1975, The biochemical clinical, and genetic features of type III hyperlipoproteinemia, Ann Intern Med, 82, 158, 10.7326/0003-4819-82-2-158 Mahley, 1990, Apolipoprotein E: Genetic variants provide insights into its structure and function, Curr Opin Lipidol, 1, 87, 10.1097/00041433-199004000-00002 Schneider, 1981, Familial dysbetalipoproteinemia: Abnormal binding of mutant apolipoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenals of rats, rabbits and cows, J Clin Invest, 68, 1075, 10.1172/JCI110330 Zannis, 1981, Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification, Biochemistry, 20, 1033, 10.1021/bi00507a059 Utermann, 1987, Apolipoprotein E polymorphism in health and disease, Am Heart J, 113, 433, 10.1016/0002-8703(87)90610-7 Davignon, 1988, Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis, 8, 1, 10.1161/01.ATV.8.1.1 Utermann, 1979, Polymorphism of apolipoprotein E: II. Genetics of hyperlipoproteinemia type III, Clin Genet, 15, 37, 10.1111/j.1399-0004.1979.tb02027.x Hazzard, 1981, Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: Relationship to dysbetalipoproteinemia and hyperlipidemia, Metabolism, 30, 79, 10.1016/0026-0495(81)90223-7 Mahley, 1985, Lipoproteins of special significance in atherosclerosis: Insights provided by studies of type III hyperlipoproteinemia, Ann NY Acad Sci, 454, 209, 10.1111/j.1749-6632.1985.tb11860.x Feussner, 1993, Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia, Hum Genet, 92, 122, 10.1007/BF00219678 Feussner, 1993, Clinical features of type III hyperlipoproteinemia. Analysis of 64 patients, Clin Invest, 71, 326, 10.1007/BF00186624 Bruckert, 1992, Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population, Atherosclerosis, 92, 105, 10.1016/0021-9150(92)90269-M Brown, 1993, The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the atherosclerosis risk in communities (ARIC) study, Arterioscler Thromb, 13, 1558, 10.1161/01.ATV.13.11.1558 Giral, 1991, Prévention Cardio-vasculaire en Médecine du travail METRA Group. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men, Arch Intern Med, 151, 950, 10.1001/archinte.151.5.950 Kapiro, 1991, Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardivascular disease, Arterioscler Thromb, 11, 1330, 10.1161/01.ATV.11.5.1330 Salonen, 1991, Ultrasonographically assessed carotid morphology and the risk of coronary heart disease, Arterioscler Thromb, 11, 1245, 10.1161/01.ATV.11.5.1245 Wofford, 1991, Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis, Arterioscler Thromb, 11, 1786, 10.1161/01.ATV.11.6.1786 Feussner, 1994, Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with type III hyperlipoproteinaemia, J Intern Med, 235, 425, 10.1111/j.1365-2796.1994.tb01098.x 1984, J Am Med Assoc, 251, 351, 10.1001/jama.251.3.351 Feussner, 1992, Screening for the apolipoprotein B-100 arginine3500 → glutamine mutation in patients with type III hyperlipoproteinemia, Clin Genet, 42, 302, 10.1111/j.1399-0004.1992.tb03260.x Luley, 1991, Rapid apolipoprotein E phenotyping by immunofixation in agarose, J Lipid Res, 32, 880, 10.1016/S0022-2275(20)42040-1 Warnick, 1979, Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3, Clin Chem, 25, 279, 10.1093/clinchem/25.2.279 Feussner, 1992, Severe type III hyperlipoproteinemia associated with unusual apolipoprotein El phenotype and ϵ1/ ‘null’ genotype, Eur J Clin Invest, 22, 599, 10.1111/j.1365-2362.1992.tb01511.x Hixson, 1990, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lipid Res, 31, 545, 10.1016/S0022-2275(20)43176-1 Statistical Analysis Systems, 1987 Conover, 1980 Schriewer, 1984, The relationship of lipoprotein(a) (Lp(a)) to risk factors for coronary heart disease, J Clin Chem Clin Biochem, 22, 591 Pedro-Botet, 1992, Lipoprotein and apolipoprotein profile im men with ischemic stroke, Stroke, 23, 1556, 10.1161/01.STR.23.11.1556 Bonithon-Kopp, 1991, Risk factor for early carotid atherosclerosis in middle-aged French women, Arterioscler Thromb, 11, 966, 10.1161/01.ATV.11.4.966 Miller, 1975, Plasma high density lipoprotein concentration and development of ischaemic heart disease, Lancet, 1, 16, 10.1016/S0140-6736(75)92376-4 Gordon, 1977, High density lipoproteins as a protective factor against coronary heart disease, Am J Med, 61, 707, 10.1016/0002-9343(77)90874-9 Senti, 1992, Lipoprotein profile in men with peripheral vascular disease: Role of intermediate density lipoproteins and apoprotein E phenotypes, Circulation, 85, 30, 10.1161/01.CIR.85.1.30 Blankenhorn, 1984, Noninvasive assessment of atherosclerosis, Prog Cardiovasc Dis, 26, 295, 10.1016/0033-0620(84)90007-0 Berglund, 1994, Ultrasound in clinical trials of atherosclerosis (Minisymposium), J Intern Med, 236, 549, 10.1111/j.1365-2796.1994.tb00843.x Craven, 1990, Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case-control study, Circulation, 82, 1230, 10.1161/01.CIR.82.4.1230 Wendelhag, 1993, Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia, Arterioscler Thromb, 13, 1401, 10.1161/01.ATV.13.10.1404 Hobbs, 1990, The LDL receptor locus in familial hypercholesterolemia: Mutational analysis of a membrane protein, Ann Rev Genet, 24, 133, 10.1146/annurev.ge.24.120190.001025 Goldstein, 1989, Familial hypercholesterolemia, 1215 Brown, 1983, Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis, Ann Rev Biochem, 52, 223, 10.1146/annurev.bi.52.070183.001255 Mahley, 1985, Atherogenic lipoproteins and coronary artery disease: Concepts derived from recent advances in cellular and molecular biology, Circulation, 72, 943, 10.1161/01.CIR.72.5.943